Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Can inactivators of plasminogen activator inhibitor alleviate the burden of obesity and diabetes? (Review).

Jankun J, Al-Senaidy A, Skrzypczak-Jankun E.

Int J Mol Med. 2012 Jan;29(1):3-11. doi: 10.3892/ijmm.2011.810. Epub 2011 Oct 11. Review.

PMID:
21993838
2.

Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

Yamamoto K, Takeshita K, Kojima T, Takamatsu J, Saito H.

Cardiovasc Res. 2005 May 1;66(2):276-85. Epub 2004 Dec 8. Review.

PMID:
15820196
3.

Plasminogen activator inhibitor-1, adipose tissue and insulin resistance.

Alessi MC, Poggi M, Juhan-Vague I.

Curr Opin Lipidol. 2007 Jun;18(3):240-5. Review.

PMID:
17495595
4.

Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.

Zhang LP, Takahara T, Yata Y, Furui K, Jin B, Kawada N, Watanabe A.

J Hepatol. 1999 Oct;31(4):703-11.

PMID:
10551395
5.

Elevated expression of transforming growth factor-beta in adipose tissue from obese mice.

Samad F, Yamamoto K, Pandey M, Loskutoff DJ.

Mol Med. 1997 Jan;3(1):37-48.

6.
7.
8.

Plasminogen activator inhibitor-1 and haemostasis in obesity.

Mutch NJ, Wilson HM, Booth NA.

Proc Nutr Soc. 2001 Aug;60(3):341-7. Review.

PMID:
11681808
9.

Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.

Kenichi M, Masanobu M, Takehiko K, Shoko T, Akira F, Katsushige A, Takashi H, Yoshiyuki O, Shigeru K.

J Lab Clin Med. 2004 Aug;144(2):69-77.

PMID:
15322501
11.

Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1.

Skurk T, Hauner H.

Int J Obes Relat Metab Disord. 2004 Nov;28(11):1357-64. Review.

PMID:
15356668
14.
15.

Expression of type-1 plasminogen activator inhibitor in the kidney of diabetic rat models.

Hagiwara H, Kaizu K, Uriu K, Noguchi T, Takagi I, Qie YL, Seki T, Ariga T.

Thromb Res. 2003;111(4-5):301-9.

PMID:
14693179
17.
18.

Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.

Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO.

Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2799-805.

PMID:
12147618
19.
20.

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I.

Diabetes. 2000 Aug;49(8):1374-80.

PMID:
10923640

Supplemental Content

Support Center